Hirai K, Ashraf M
Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, Cincinnati, OH, 45267, USA.
J Mol Cell Cardiol. 1998 Sep;30(9):1803-15. doi: 10.1006/jmcc.1998.0745.
We investigated whether xanthine oxidase-derived superoxide radical generation could be modified by interfering with adenosine transport and metabolism in reducing myocardial injury during post-ischemic reperfusion. Isolated rat hearts perfused at constant pressure were subjected to 20 min of pretreatment with test agents, followed by 40 min global ischemia and 30 min reperfusion with or without test agents. In hearts treated with adenosine deaminase inhibitor, erythro 9-(2-hydroxy-3-nonyl) adenine (EHNA), alone or together with a selective nucleoside transport blocker, p-nitrobenzylthioinosine (NBMPR), the accumulated amount of O-2. was significantly reduced [10.2+/-0.97, 11.6+/-2.4, 8.1+/-0.51, respectively, v 31.6+/-2.1 (s. e.) nmol/wet g/30 min in ischemic control, P<0.01]. A positive correlation between O-2. and inosine release was observed in the initial 5 min of reperfusion in hearts treated with either EHNA or NBMPR ( r=0.475, P<0.05). Furthermore, the accumulated amount of LDH release showed positive correlation with that of O-2. among the same groups (r=0.474, P<0.05). Both EHNA and NBMPR had the cardioprotective effect on the recovery of left ventricular end-diastolic pressure (LVEDP), ATP repletion, and build up of endogenous adenosine. This study suggests that : (1) adenosine metabolism can be manipulated towards the formation of O-2. during reperfusion, and it has an important bearing on the cardiac recovery of ischemic myocardium, (2) the generation of O-2. is related to only inosine release during initial reperfusion.
我们研究了在减少缺血后再灌注期间心肌损伤过程中,通过干扰腺苷转运和代谢是否可以改变黄嘌呤氧化酶衍生的超氧阴离子的生成。将恒压灌注的离体大鼠心脏用测试剂预处理20分钟,然后进行40分钟全心缺血和30分钟再灌注(有或无测试剂)。在用腺苷脱氨酶抑制剂erythro 9-(2-羟基-3-壬基)腺嘌呤(EHNA)单独或与选择性核苷转运阻滞剂对硝基苄硫基肌苷(NBMPR)联合处理的心脏中,O₂⁻的累积量显著降低[分别为10.2±0.97、11.6±2.4、8.1±0.51,与缺血对照组的31.6±2.1(标准误)nmol/湿重g/30分钟相比,P<0.01]。在用EHNA或NBMPR处理的心脏再灌注的最初5分钟内,观察到O₂⁻与肌苷释放之间呈正相关(r=0.475,P<0.05)。此外,在同一组中,乳酸脱氢酶释放的累积量与O₂⁻的累积量呈正相关(r=0.474,P<0.05)。EHNA和NBMPR对左心室舒张末期压力(LVEDP)的恢复、ATP补充以及内源性腺苷的积累均具有心脏保护作用。本研究表明:(1)在再灌注期间,腺苷代谢可被调控以促进O₂⁻的形成,这对缺血心肌的心脏恢复具有重要影响;(2)O₂⁻的生成仅与再灌注初期的肌苷释放有关。